Previous 10 | Next 10 |
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression, social anxiety disorder and other central nervous system (CNS) diseases and disorders with high unm...
In 2017 researchers from the University of Oxford's Department of Psychiatry proclaimed no new antidepressants would likely come to market in the next decade. Despite this lousy prediction, March 2019 saw the approval of Johnson & Johnson's ( JNJ ) esketamine (Spravato) for treatment...
The following slide deck was published by VistaGen Therapeutics, Inc. in conjunction with this Read more ...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 14, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) diseases and disorders with high unmet need, today announced th...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 13, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) diseases and disorders with high unmet need, today announced th...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression, social anxiety disorder and other central nervous system (CNS) diseases and disorders with high unmet ...
CORAL GABLES, FL / ACCESSWIRE / February 27, 2019 / Nothing in life is guaranteed, but based on the first few months of the year, the future of the tech stock market looks to be in good shape. Driven by the activity in the tech industry, companies in the space have demonstrated in 2019 tha...
Gainers: FTE Networks (NYSEMKT: FTNW ) +123% . Telaria (NYSE: TLRA ) +35% . Ferroglobe PLC (NASDAQ: GSM ) +27% . EverQuote (NASDAQ: EVER ) +26% . Vitamin Shoppe (NYSE: VSI ) +25% . Heidrick & Struggles International (NASDAQ: HSII ) +24% . Key Energy Services (NYSE: KEG ) +...
VistaGen Therapeutics (NASDAQ: VTGN ) -23% on announcing stock offering. More news on: VistaGen Therapeutics, Inc., TransEnterix, Inc., China Internet Nationwide Financial Services Inc., Stocks on the move, Read more ...
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) diseases and disorders with high unmet need, today anno...
News, Short Squeeze, Breakout and More Instantly...
VistaGen Therapeutics Inc. Company Name:
VTGN Stock Symbol:
NASDAQ Market:
VistaGen Therapeutics Inc. Website:
Vistagen Therapeutics (NASDAQ: VTGN ), a clinical-stage, neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, has received multiple new patent...
Vistagen (Nasdaq: VTGN), a clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today announced the broadening of its global in...
Vistagen (NASDAQ: VTGN) , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that it has been recognized by Mental Health America (“MHA”) for its dedication to pr...